Tag: #Global Trends

Key Development Sweden-based health technology company Neko Health has secured $700 million in Series C financing as it prepares to... Read more

Key Development The cell therapy industry is entering a new stage of maturity, where manufacturing capability is becoming just as... Read more

The U.S. Food and Drug Administration (FDA) has approved Revtorpyk (gedatolisib), developed by Celcuity, for certain patients with advanced or... Read more

AstraZeneca has entered into an exclusive global licensing agreement with China's Dizal Pharmaceutical for Zegfrovy (sunvozertinib), an oral targeted therapy... Read more

The rapid expansion of GLP-1 receptor agonists has fundamentally reshaped obesity management, but a new study suggests that the next... Read more

The United States is experiencing a significant increase in reported cyclosporiasis cases, a foodborne parasitic infection caused by Cyclospora cayetanensis.... Read more

The U.S. Food and Drug Administration (FDA) has approved an at home starting dose option for Leqembi (lecanemab), allowing eligible... Read more

Novo Nordisk has announced positive results from the Phase III FRONTIER4 extension study, reinforcing the long term safety and efficacy... Read more

AstraZeneca has expanded its oncology pipeline through a new licensing agreement with Dizal Pharmaceutical, securing global rights outside mainland China... Read more